Walgreens's U.S. pharmacy sales climb

Walgreens Boots Alliance reports growth in prescription volumes helped increase pharmacy sales in its latest quarter, as the company's integration of Rite Aid stores expanded its foothold in the U.S. prescription market. Walgreens’s share of the U.S.

Walgreens Boots Alliance reports growth in prescription volumes helped increase pharmacy sales in its latest quarter, as the company's integration of Rite Aid stores expanded its foothold in the U.S. prescription market. Walgreens’s share of the U.S. retail prescription market this year has grown to a company record 21.7%, compared with 20.2% in 2017, Walgreens Chief Financial Officer James Kehoe said Thursday, citing data from health care research firm Iqvia. For the fourth quarter, Walgreens filled the largest number of prescriptions in its history, mainly due to its retention of many Rite Aid prescription drug customers after taking over those stores. U.S. pharmacy sales rose 17% from the year-earlier quarter while prescriptions filled in comparable stores increased 1.3%. Overall sales rose 11% to $33.44 billion. Growth in Walgreens's pharmacy business helped offset weakness in sales of general merchandise and personal care items. Comparable U.S. retail sales in the fourth quarter fell 1.9% from a year earlier.